This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

An Update

Ann L. Vercoutere, MD; Theodore X. O'Connell, MD

Arch Surg. 1984;119(11):1301-1304.

Abstract
• The majority of reports in the literature that have documented poor survival in men with breast cancer have originated from major cancer centers and military hospitals. In contrast, we reviewed 45 men with breast cancer from seven community-based medical centers. Of the patients who were seen, 55% had localized disease (stage I), 39% had disease that was confined to the axilla (stage II), and 6% had metastatic disease (stage III). The survival data was compared with that of 2,620 women treated during the same time interval. The comparison showed a survival advantage for the men. This variance in survival data obtained from previously published reports may be due to a generally early stage of disease seen in community hospitals as compared with major referral centers.

(Arch Surg 1984;119:1301-1304)

Author Affiliations
From the Kaiser Permanente Medical Group, Los Angeles.

Footnotes
Accepted for publication July 2, 1984.

Read before the Annual Meeting of the Southern California Chapter of the American College of Surgeons, Santa Barbara, Calif, Jan 28, 1984.

Reprint requests to Department of Surgery, Kaiser Permanente Medical Group, 1526 N Edgemont, Los Angeles, CA 90027 (Dr O'Connell).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tamoxifen in the Treatment of Breast Cancer
Osborne
NEJM 1998;339:1609-1618.
FULL TEXT